Interdict Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$17.5M
- Investors
-
3
Interdict Bio General Information
Description
Developer of a small-molecule therapeutics platform designed to address historically undruggable targets. The company's platform specializes in addressing strongly validated yet historically undruggable targets in oncology, rare diseases, neurodegeneration, and autoimmunity, enabling healthcare professionals to treat their patients effectively.
Contact Information
Website
www.interdictbio.comCorporate Office
- 201 Haskins Way
- Suite 507
- South San Francisco, CA 94080
- United States
Corporate Office
- 201 Haskins Way
- Suite 507
- South San Francisco, CA 94080
- United States
Interdict Bio Timeline
Interdict Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 10-Sep-2025 | $17.5M | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC | 01-Jun-2023 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 28-Mar-2022 | $9M | $9M | Completed | Pre-Clinical Trials |
Interdict Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Interdict Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Interdict Bio Patents
Interdict Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12698280-B2 | Small molecule protein synthesis modulators | Active | 19-Sep-2024 | ||
| US-20260078116-A1 | Small molecule protein synthesis modulators | Active | 19-Sep-2024 | ||
| US-20260109696-A1 | Small molecule protein synthesis modulators | Pending | 19-Sep-2024 | ||
| WO-2026064572-A1 | Small molecule protein synthesis modulators | Pending | 19-Sep-2024 | ||
| WO-2026064579-A2 | Small molecule protein synthesis modulators | Pending | 19-Sep-2024 | C07D417/10 |
Interdict Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Interdict Bio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mission Bay Capital | Venture Capital | Minority | ||
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| Venrock | Venture Capital | Minority |
Interdict Bio FAQs
-
When was Interdict Bio founded?
Interdict Bio was founded in 2022.
-
Where is Interdict Bio headquartered?
Interdict Bio is headquartered in South San Francisco, CA.
-
What is the size of Interdict Bio?
Interdict Bio has 14 total employees.
-
What industry is Interdict Bio in?
Interdict Bio’s primary industry is Biotechnology.
-
Is Interdict Bio a private or public company?
Interdict Bio is a Private company.
-
What is the current valuation of Interdict Bio?
The current valuation of Interdict Bio is .
-
What is Interdict Bio’s current revenue?
The current revenue for Interdict Bio is .
-
How much funding has Interdict Bio raised over time?
Interdict Bio has raised $26.5M.
-
Who are Interdict Bio’s investors?
Mission Bay Capital, Altitude Life Science Ventures, and Venrock have invested in Interdict Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
